Development and preliminary validation of a patient-report experience measure of acute oncology: The PREMAC study

Richard Wagland, Anna Hurley-Wallace, John Defty, M. Jamal Hossain, Alison Richardson

Abstract

Patients with cancer often experience oncological emergencies requiring immediate care, and the quality of acute oncology (AO) care varies between providers. Patient-reported experience measures (PREMs) are a key tool for quality improvement, but none currently exists for AO.

Introduction

Almost 20 million new cases of cancer were diagnosed globally in 2022, and cancer is expected to become the leading cause of premature death worldwide [1]. With treatment advances, the numbers of patients with a cancer diagnosis receiving treatment within community settings are increasing [2,3].

Materials and methods

Frameworks exist to evaluate quality of patient-reported questionnaires and determine usability in a patient population. For this study, the Quality Assessment Criteria framework devised by Pesudovs et al. (2007) [23] was used, specifically the stages up to and including the development of a prototype PREM within one site.

Results

Sixteen articles reporting on 14 unique studies were included. Issues important to patient experiences of emergency cancer care were described by patients, healthcare professionals and carer proxies [22].

Discussion

International guidance on cancer care emphasises the importance of patient experience [31], which has been associated with clinical effectiveness and patient safety [32]. A key purpose of PREMs is to measure patients’ experiences of care and thus drive quality improvement [33]. 

Conclusion

The PREMAC study contributes to the international focus on patient-centred care for people with cancer experiencing an oncological emergency. PREMAC appears to be the first patient-reported experience measure developed specifically for AO. 

Citation: Wagland R, Hurley-Wallace A, Defty J, Hossain MJ, Richardson A (2026) Development and preliminary validation of a patient-report experience measure of acute oncology: The PREMAC study. PLoS One 21(10): e0359781. https://doi.org/10.1371/journal.pone.0359781

Editor: César Leal-Costa, Murcia University, Spain, SPAIN

Received: October 21, 2025; Accepted: September 17, 2026; Published: October 27, 2026

Copyright: © 2026 Wagland et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Data Availability: The minimal data set is available at the Open Science Framework (OSF) via https://osf.io/a34ux/files/osfstorage.

Funding: This study was funded by the University Hospital Southampton NHS Foundation Trust Small Grants Scheme. Grant number: GRT0710 (RW, AR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Competing interests: The authors have declared that no competing interests exist.